| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $97,4850 | +3,03% | $1,44B | $66,37K | |
TMP Tompkins Financial Corporation | $99,0950 | -1,16% | $1,44B | $15,95K | |
BRUN Boost Run Inc. Class A Common Stock | $18,2560 | -9,29% | $1,44B | $792,72K | |
TWFG TWFG, Inc. Common Stock | $27,2350 | +1,70% | $1,44B | $51,97K | |
PCT PureCycle Technologies, Inc. Common stock | $7,0870 | +3,01% | $1,44B | $714,42K | |
REX REX American Resources Corp. | $44,3800 | +0,59% | $1,43B | $10,77K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $8,0010 | -4,18% | $1,43B | $17,03K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,6510 | +0,27% | $1,43B | $5,40K | |
ADNT Adient plc Ordinary Shares | $19,8900 | +2,11% | $1,43B | $45,37K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04% | $1,43B | $1,83M | |
| $37,6350 | +0,20% | $1,43B | $101,57K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $2,8450 | -8,81% | $1,43B | $258,03K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $17,6050 | +3,50% | $1,42B | $14,98K | |
REPL Replimune Group, Inc. | $15,1980 | -2,45% | $1,42B | $1,13M | |
HCSG Healthcare Services Group | $23,4130 | +6,71% | $1,42B | $153,88K | |
